CAYMAN CHEMICAL
BMN 673-25 mg
An orally available PARP1 and PARP2 inhibitor (Kis = 1.2 and 0.85 nM, respectively) selectively targets tumor cells with BRCA1, BRCA2, or PTEN gene mutations and elicits antitumor activity in xenografted tumors.
An orally available PARP1 and PARP2 inhibitor (Kis = 1.2 and 0.85 nM, respectively) selectively targets tumor cells with BRCA1, BRCA2, or PTEN gene mutations and elicits antitumor activity in xenografted tumors.
Specifications
- UPC:
- 51143005
- Condition:
- New
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- Quantity:
- 1
- Unit of Measurement:
- EA
- WeightUOM:
- LB
- MPN:
- 19782-25



